NCT02103595View on ClinicalTrials.gov

A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Diabetes Mellitus Type 2, Diabetes Mellitus Type 1
Interventions
DEVICE

Accu-Chek FlexLink

Insulin pump device used for 4-weeks under real life conditions

DEVICE

Accu-Chek FlexLink Plus

Insulin pump device used for 4-weeks under real life conditions

Trial Locations (5)

13597

Berlin

18057

Rostock

63739

Aschaffenburg

89081

Ulm

01627

Berlin

All Listed Sponsors
collaborator

Roche Diagnostics GmbH

INDUSTRY

lead

Hoffmann-La Roche

INDUSTRY

NCT02103595 - A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients. | Biotech Hunter | Biotech Hunter